A 67-year-old man underwent percutaneous balloon valvuloplasty for bioprosthetic tricuspid stenosis. He had undergone two tricuspid valve replacements over a period of 39 years and became symptomatic. After the valvuloplasty, his symptoms were resolved. Stenosis of a bioprosthetic tricuspid valve can be successfully and safely treated with balloon valvuloplasty.
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CASE DESCRIPTION
A 67-year-old man was referred for evaluation for possible percutaneous balloon valvuloplasty because of stenosis of a bioprosthesis in the tricuspid valve position. Th e patient had originally undergone excision of a right atrial myxoma and tricuspid valve replacement by Dr. Denton Cooley at the age of 28. At the age of 55, his fatigue increased and lowerextremity edema worsened. Th e stenotic bioprosthesis in the tricuspid valve was replaced again with a 25 mm CarpentierEdwards pericardial bioprosthesis. Over the past year, he had been experiencing increasing amounts of lower-extremity edema, fatigue, and ascites. Echocardiography disclosed a mean gradient of 15 mm Hg across the bioprosthetic tricuspid valve. Th e patient did not wish to undergo a third sternotomy and was referred to our institution. Examination disclosed sinus rhythm, 2/6 diastolic murmur loudest over the left sternal border, hepatosplenomegaly, ascites, and trace tibial edema.
Right-sided cardiac catheterization via the right femoral vein disclosed a 9 mm Hg gradient between the right atrium and right ventricle (Figure 1a) . A 0.035 inch, 260 cm long J-tipped wire was placed into the left pulmonary artery, which allowed a 25 mm × 4 cm Z-Med II Balloon (Braun Interventional Systems, Bethlehem, PA) to be placed across the bioprosthetic tricuspid valve. Once infl ation was complete, the mean pressure gradient was reduced to 5 mm Hg (Figures 1b and 2 ). Postprocedure transthoracic echocardiography showed that the mean gradient was reduced from 9 mm Hg to 6 mm Hg. Th e patient tolerated the procedure well and was discharged home the following day. At 3-month follow-up, his fatigue, ascites, and peripheral edema had resolved.
DISCUSSION
Percutaneous balloon valvuloplasty is commonly used to treat patients with aortic and mitral stenosis. Our patient with a stenotic bioprosthetic tricuspid valve was treated with balloon valvuloplasty. Th is has been previously reported, and data from these cases are summarized in Table 1 .
